Literature DB >> 13173473

[Vasomotor effect of heparin in normal individuals and in patients with Raynaud's disease].

E STORTI, F VACCARI, G SCARDOVI.   

Abstract

Entities:  

Keywords:  HEPARIN/therapeutic use; RAYNAUD'S DISEASE/therapy

Mesh:

Substances:

Year:  1954        PMID: 13173473     DOI: 10.1007/BF02159286

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  8 in total

1.  [Heparin in the treatment of arteritis of the lower extremities].

Authors:  M REMY; P CADIOT; C PERNOT
Journal:  Presse Med       Date:  1953-07-04       Impact factor: 1.228

2.  [A new therapy of hypertension].

Authors:  R KELLER
Journal:  Praxis       Date:  1953-01-08

3.  Heparin in the treatment of advanced peripheral atherosclerosis; a preliminary report.

Authors:  H ENGELBERG; T B MASSELL
Journal:  Am J Med Sci       Date:  1953-01       Impact factor: 2.378

4.  [Clinical and physiopathological considerations in the treatment of angina with heparin].

Authors:  E DONZELOT; H KAUFMANN; J M LE BOZEC
Journal:  Sem Hop       Date:  1953-05-10

5.  The effect of heparin and dicumarol in increasing the coronary flow volume.

Authors:  N C GILBERT; L A NALEFSKI
Journal:  J Lab Clin Med       Date:  1949-06

6.  [Anticoagulant therapy of stenocardiac syndromes].

Authors:  R CATALDI
Journal:  Minerva Med       Date:  1952-01-23       Impact factor: 4.806

7.  An attempt to forestall acute coronary thrombosis; preliminary note on the continuous use of dicumarol.

Authors:  E S NICHOL; D W FASSETT
Journal:  South Med J       Date:  1947-08       Impact factor: 0.954

8.  Blood lipids and human atherosclerosis.

Authors:  J W GOFMAN; H B JONES; F T LINDGREN; T P LYON; H A ELLIOTT; B STRISOWER
Journal:  Circulation       Date:  1950-08       Impact factor: 29.690

  8 in total
  1 in total

1.  [Effects of heparin on experimental hypertension in rats].

Authors:  W HARDEGG; W MAASS; G MAYER; H ABEL; K HUHNSTOCK
Journal:  Klin Wochenschr       Date:  1955-09-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.